Pay in 4 interest-free payments of $6.62 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Results are typically gradual and progressive
You might get them weekly at first and then less often
These patients face elevated b12 deficiency risk regardless of medication use
Overall Safety and Tolerability Assessment The primary safety conclusion from the comprehensive trial program was unambiguous: AOD-9604 displayed a very good safety and tolerability profile indistinguishable from placebo
Anyone suspecting deficiency should consult their GP rather than self-treating with over-the-counter supplements, which may not provide adequate doses for clinical correction
US$ 29.20
US$ 25.95
US$ 23.41
US$ 26.38
US$ 24.78
US$ 28.29
